A space for information & research. Not for sale.

The beauty of peptide science

Small molecules.
Extraordinary
possibilities.

A considered introduction to GHK-Cu, KPV, and Tirzepatide. Explore the molecules, understand the research, and discover a clearer perspective.

Explore the collectionAsk us a question

For knowledge. For research. Not for human use.

The Peptiglows edit · Packaging illustration
Three focused peptide profiles
Grounded in published research
Clearly stated specifications
Curiosity, with clarity

The curated collection

Three peptides. A closer look.

Distinct molecules. Different areas of study. Get to know the science, research focus, and specifications behind each one.

01Copper peptide

GHK-Cu

100 mg

The science of renewal.

A naturally occurring copper-binding tripeptide studied for its role in collagen synthesis and tissue repair. A fascinating focus of skin-related laboratory research.

  • Collagen synthesis in cell studies
  • Tissue repair in preclinical models
  • Copper–peptide biology
Blue powder3 or 7 mL clear vial
02Tripeptide

KPV

10 mg

A study in balance.

Lysine–proline–valine: a three-amino-acid peptide investigated for anti-inflammatory activity in cell and animal studies. Small in structure, intriguing in research.

  • Inflammatory signaling pathways
  • Intestinal and immune cell models
  • Peptide transport mechanisms
White powder3 mL clear vial
03Dual receptor agonist

Tirzepatide

10 mg

Two pathways. One molecule.

A peptide that activates GIP and GLP-1 receptors. The active ingredient in prescription medicines studied for blood glucose control and chronic weight management.

  • Dual GIP + GLP-1 receptor activity
  • Glucose regulation
  • Clinical weight-management evidence
White powder3 mL clear vial

All profiles list 99% purity as a supplied specification; independent batch verification has not been provided. Images are packaging illustrations. Research findings do not establish the safety or effectiveness of these vials for human use.

An invitation to understand more

The Peptiglows perspective

Beautifully considered.
Clearly explained.

The world of peptides deserves a thoughtful introduction. We bring the essentials together, with room for curiosity and respect for what the evidence actually says.

Evidence before promises

Published studies provide context. We distinguish laboratory findings from clinical evidence in people.

The details, made transparent

Peptide identity, stated contents, vial size, and powder appearance. Supplied specifications are identified as such.

A space dedicated to learning

Educational profiles and research inquiries. No sales, treatment plans, or instructions for personal use.

A little more clarity

Good questions.
Thoughtful answers.

A few things to know as you explore the science behind the collection.

Have another question?
What is Peptiglows?
Peptiglows is an information and research landing page exploring GHK-Cu, KPV, and Tirzepatide. We bring together concise research summaries and supplied packaging specifications to make these molecules easier to understand.
Are these products available to purchase?
No. The vials shown are for information and research context only and are not offered for sale. WhatsApp is for questions about the information on this page, not orders or prescriptions.
Do research findings mean proven benefits?
No. Findings from cells or animals do not prove that a peptide will provide a benefit in people. Evidence for an approved medicine also cannot be transferred to a different formulation or research vial. Each profile explains the relevant evidence and its limits.
What does the 99% purity specification mean?
It is the purity figure supplied for each peptide profile. Peptiglows has not been provided with an independent, batch-specific certificate of analysis. A purity percentage alone does not establish identity, sterility, safety, or suitability for human use.
Is the Tirzepatide vial an approved medicine?
The illustrated research powder vial is not presented as an approved medicine. Clinical information refers to regulated prescription tirzepatide products with specific formulations and indications. Any treatment decision belongs with a qualified healthcare professional.
Can you provide dosing or personal medical advice?
No. Peptiglows does not provide dosing, reconstitution, injection instructions, or individual medical advice. These profiles are educational. Please speak with a qualified healthcare professional about personal health or treatment questions.

Curiosity starts a conversation

Let’s explore the science together.

Have a question about a peptide profile or its specifications?
Start a thoughtful conversation with Peptiglows.

Connect on WhatsApp

Research inquiries only. No sales or medical consultations.

01 / Copper peptide

GHK-Cu

Glycyl-L-histidyl-L-lysine copper

The research in focus

GHK is a naturally occurring tripeptide with an affinity for copper. A study of cultured fibroblasts found that GHK-Cu stimulated collagen synthesis.[1] A separate rat wound study reported increased connective-tissue components, including collagen.[2]

What this means

These findings explain the interest in skin and tissue-repair research. They do not establish clinical benefits, hair regrowth, or the safety of this research vial in people.

Stated contents
100 mg
Vial
3 mL or 7 mL · clear glass
Powder appearance
Blue
Stated purity
99% · supplied specification

Specifications are supplied by Peptiglows. No independent batch certificate has been provided. Vial capacity is not a dosing instruction.

Information and research only. Not for sale or human use.

Ask about GHK-Cu

02 / Tripeptide

KPV

Lysine–proline–valine

The research in focus

In a published study, KPV reduced inflammatory signaling in intestinal epithelial and immune cell models. Researchers also observed anti-inflammatory effects in mouse models of colitis and investigated uptake through the PepT1 transporter.[3]

What this means

This is preclinical evidence. It does not establish KPV as a treatment for skin redness, inflammation, or any condition in people. Human safety and effectiveness cannot be inferred from these models.

Stated contents
10 mg
Vial
3 mL · clear glass
Powder appearance
White
Stated purity
99% · supplied specification

Specifications are supplied by Peptiglows. No independent batch certificate has been provided. Vial capacity is not a dosing instruction.

Information and research only. Not for sale or human use.

Ask about KPV

03 / Dual receptor agonist

Tirzepatide

GIP + GLP-1 receptor activity

The clinical context

Tirzepatide activates two hormone receptors involved in glucose regulation. In the United States, the prescription medicine Mounjaro is approved for type 2 diabetes;[4] Zepbound has specific weight-management and obstructive sleep apnea indications.[5] These approvals apply to regulated medicines, not the powder vial illustrated here.

Benefits require safety context

Prescription tirzepatide can cause nausea, vomiting, diarrhea, and other gastrointestinal effects. Serious risks include pancreatitis and gallbladder disease. U.S. labeling carries a boxed warning about thyroid C-cell tumors observed in rats; the relevance to humans is unknown. It is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. See the full prescribing information.[5]

Stated contents
10 mg
Vial
3 mL · clear glass
Powder appearance
White
Stated purity
99% · supplied specification

Supplied research specifications, not an approved medicine presentation. No independent batch certificate has been provided.

Information and research only. Not for sale or human use. This page does not provide dosing or treatment guidance.

Ask about Tirzepatide

The evidence behind the profiles

Research sources

Primary publications and official U.S. prescribing information. Links open in a new tab. Evidence checked September 2026.

  1. GHK-Cu and collagen synthesis in fibroblast culturesMaquart et al. · FEBS Letters · 1988 · Cell study
  2. GHK-Cu and connective-tissue accumulation in experimental woundsMaquart et al. · Journal of Clinical Investigation · 1993 · Rat study
  3. PepT1-mediated KPV uptake and intestinal inflammationDalmasso et al. · Gastroenterology · 2008 · Cell and mouse studies
  4. Mounjaro (tirzepatide): full U.S. prescribing informationEli Lilly and Company · Official medicine labeling · PDF
  5. Zepbound (tirzepatide): full U.S. prescribing informationEli Lilly and Company · Official medicine labeling · PDF

Research is context, not a promise of results. These sources do not verify the identity, purity, sterility, or safety of any Peptiglows vial.